Spark Venture Management

Spark Venture Management is a London-based venture capital firm founded in 2005, specializing in early-stage investments primarily in the technology, media, and healthcare sectors across the UK and Europe. With over 12 years of experience, the firm focuses on high-growth potential companies, providing equity investments to support their development from startup to eventual trade sale or initial public offering. Spark Venture Management is committed to leveraging its expertise to foster innovation and drive success in the consumer technology landscape.

Anthony Duffy

Founder and Director

43 past transactions

Unmarshal

Seed Round in 2021
Unmarshal is a Decentralized network of blockchain data indexers and transforming tools to power DeFi applications on any chain.

Study119.com

Seed Round in 2019
Study119.com is a professional firefighter education and training service platform.

MyOffer

Series B in 2018
MyOffer is a Shenzhen-based online overseas study application platform. It provides information on over one million courses available at universities around the world. The company plans to expand its business in the field of visa application, accommodation, careers planning, overseas experience, and employment for overseas students.

Simba Sleep

Venture Round in 2016
Simba Sleep is an e-commerce company that offers a variety of mattresses. It brings together thousands of super-light comfort springs and support from precision-engineered foam in perfect harmony. The company is driven by a mission is to bring the importance of sleep back into focus, and help everyone wake up winning. Simba Sleep was founded in 2015 and is headquartered in London, England.

Simba Sleep

Series A in 2016
Simba Sleep is an e-commerce company that offers a variety of mattresses. It brings together thousands of super-light comfort springs and support from precision-engineered foam in perfect harmony. The company is driven by a mission is to bring the importance of sleep back into focus, and help everyone wake up winning. Simba Sleep was founded in 2015 and is headquartered in London, England.

Sky Medical Technology

Seed Round in 2014
Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatory conditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.

Vigil Monitoring

Series A in 2013
Vigil is a privately owned New Zealand company founded in 2012. Our​ system improves healthcare outcomes in home based personal healthcare management, hospital and managed care environments. Our industry specific hardware and software packages can be tailored to meet individual customer needs and integrated into existing operational systems, improving cost efficiency, quality of care and healthcare outcomes. They are designed operate with different devices and applications, providing end-to-end connectivity that means device users [wearers], their friends and family and other service providers [carers] can easily access data about the wearer, their wellbeing, their location and their environment.

Haemostatix

Venture Round in 2012
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Zilico

Venture Round in 2012
Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.

Oxford Immunotec

Venture Round in 2012
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Alchemy Pharmatech

Venture Round in 2012
Alchemy Pharmatech is an innovation-driven company developing drug delivery platforms in partnership with the pharmaceutical industry.

Celoxica

Venture Round in 2012
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Haemostatix

Series C in 2011
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Vivacta

Venture Round in 2010
Vivacta Limited, a Sittingbourne, UK-based medical diagnostics company that develops an innovative platform for point of care testing. Vivacta’s innovative piezofilm technology platform enables the advancement of new near‐patient diagnostic products. The company has successfully developed a test for thyroid stimulating hormone (TSH), and is working on a multiple analyte cardiovascular diagnostic test for use in the emergency room and acute care settings, where there is a need for rapid diagnosis of possible heart attack and related time‐critical medical conditions.

Haemostatix

Venture Round in 2010
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Celoxica

Venture Round in 2010
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Oxford Immunotec

Series D in 2010
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Academia.edu

Angel Round in 2010
Academia.edu is the largest and fastest-growing platform in the world for sharing academic research. Its mission is to accelerate and democratize academic research. Over 150 million academics have signed up to Academia.edu, adding 25 million papers. Over 100,000 people join Academia.edu each day. Academia.edu attracts over 52 million unique visitors a month. 40% of the world's faculty log in to Academia.edu every month. The company was founded in 2008 and is headquartered in San Francisco, California.

Celona Techlogies

Venture Round in 2010
Celona Technologies Ltd. specializes in application data migration software designed to facilitate organizational changes. The company offers a suite of tailored software solutions that enable the seamless migration of applications, data, users, and processes without downtime. Key products include Celona Evolve, which manages the migration and bi-directional synchronization of application data and business processes, alongside features such as a management dashboard, migration scheduler, and exception management solutions. The company also provides Application Adaptors that support data migration from legacy systems to new applications. Celona Technologies serves diverse industries, including telecommunications, financial services, utilities, retail, and the public sector, addressing needs in billing, CRM, ERP, and inventory management. Founded in 2005 and headquartered in London, the company has expanded its presence to Europe and the Asia Pacific region.

Vivacta

Venture Round in 2009
Vivacta Limited, a Sittingbourne, UK-based medical diagnostics company that develops an innovative platform for point of care testing. Vivacta’s innovative piezofilm technology platform enables the advancement of new near‐patient diagnostic products. The company has successfully developed a test for thyroid stimulating hormone (TSH), and is working on a multiple analyte cardiovascular diagnostic test for use in the emergency room and acute care settings, where there is a need for rapid diagnosis of possible heart attack and related time‐critical medical conditions.

OMGPOP

Series B in 2009
OMGPOP is a leading developer of social games for facebook, iphone and the open web. With games on multiple social networks as well as its own destination site, the company is recognized as a leader in creating real-time game experiences.

Mind Candy

Convertible Note in 2009
Moshi provides a sleep and mindfulness app for kids featuring melodic stories created to help kids drift off to sleep quickly, calming guided meditation sessions with a playful Moshi twist, created to help kids relax and learn the basics of mindfulness, and a collection of completely original instrumentals, specifically composed to soothe and relax.

Antenova

Venture Round in 2008
Antenova, Ltd. engages in the design, development, and supply of standard and custom antennas, and radio frequency antenna modules. Its products are used in mobile handsets, adapters, portable devices, laptop computers, and wireless devices. Antenova, Ltd. was incorporated in 1999 and is headquartered in Stow-cum-Quy, the United Kingdom. It has design, and sales and support centers in Taipei, Taiwan; Chicago, Illinois; and Shanghai, China, as well as manufacturing operations in Taiwan and China.

Secerno

Series B in 2008
Secerno is the technology leader in active database control. Their UK headquarters are in Oxford and their US headquarters in Bedminster, New Jersey. Their Secerno DataWall™ solutions are the new approach to controlling how data in databases is accessed. Secerno DataWall includes database activity monitoring, database policy enforcement and database compliance auditing solutions – available as a range of either hardware or virtual appliances.

Celoxica

Venture Round in 2008
Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Haemostatix

Venture Round in 2008
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Kobalt

Series B in 2008
Kobalt is a music artist management company that offers alternatives to traditional music business models. It provides technology solutions for a more transparent, efficient and empowering future for rights owners. Regardless of how complex the music industry becomes, Kobalt is determined to create a future where every artist, songwriter and publisher is paid fairly and accurately. Kobalt's Music Publishing, Label Services and Neighbouring Rights divisions each offer a modern alternative to the traditional music business model, empowering creators with transparency, flexibility, ownership and control. With over 275 employees in offices around the world, Kobalt represents over 8,000 artists and songwriters, 600,000 songs and 450 publishing companies, providing them with real-time, powerful, transparent reporting through the award-winning Kobalt Portal. Kobalt also services its clients with global licensing management, works and rights distribution, royalty collection and processing, online data and royalty statements, creative services, synch & brand partnerships, record release management and digital marketing. Kobalt works with some of the world's greatest artists and songwriters, representing on average over 40% of the top 100 songs and albums in both the US and UK. Kobalt clients include Maroon 5, Lenny Kravitz, Dave Grohl, Max Martin, Bob Dylan, Pitbull, Ellie Goulding, Macklemore & Ryan Lewis, One Republic, Simon & Garfunkel, Passenger, Akon, Ryan Tedder, Paul McCartney and MPL Communications, Disney Music Group, Dr Luke, David Gray, Big & Rich, Stevie Nicks, Gwen Stefani, Nick Cave and the Bad Seeds, Noah Shebib, Thom Yorke, The Hives, The Lumineers, Richard Ashcroft, Björk, Kelly Clarkson, Gotye, Skrillex, Herbie Hancock, Moby, Kid Cudi, Joss Stone and the Miles Davis catalog among many others.

blinkbox music

Series A in 2008
blinkbox music is an ad-supported music streaming service and an integrated MP3 store providing an easy way to listen to music. Its listeners can choose from thousands of stations based around themes such as Top 40 Songs, Ultimate 80s Pop, Dinner Party, or create their own by starting with a song, artist, or genre. Its listeners have the ability to listen to blinkbox music for free on the web, as well as through its mobile and tablet apps on both Android and iOS. Its listeners can even save their favorite stations to their mobile or tablet to listen when they don't have an internet connection. blinkbox music was launched in 2007 and is based in Oxford.

Vivacta

Series B in 2007
Vivacta Limited, a Sittingbourne, UK-based medical diagnostics company that develops an innovative platform for point of care testing. Vivacta’s innovative piezofilm technology platform enables the advancement of new near‐patient diagnostic products. The company has successfully developed a test for thyroid stimulating hormone (TSH), and is working on a multiple analyte cardiovascular diagnostic test for use in the emergency room and acute care settings, where there is a need for rapid diagnosis of possible heart attack and related time‐critical medical conditions.

Skinkers

Series B in 2007
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).

EDEM Simulation

Venture Round in 2007
EDEM develops and markets high performance discrete element method (DEM) simulation software, a CAE tool designed for simulation-based engineering of equipment that handle or process bulk particles. Bulk particles, also known as bulk materials or bulk solids, such as powders, granules, tablets and aggregates, are handled and processed in every major manufacturing and process industry, including, pharmaceutical, food processing, consumer packaged goods, mining, minerals processing, metals manufacturing, and construction and agricultural machinery. The Company’s ground-breaking EDEM Simulation Software provides advanced engineering and operational benefits to all industries handling and processing bulk materials, enabling them to reduce design prototyping time and costs, optimize equipment performance, increase productivity and operational efficiencies, and enhance product innovation. DEM Solutions provides EDEM® simulation software platform, EDEM BulkSim® software, and engineering support services to blue-chip companies around the world in mining & energy, equipment manufacturing and process industries. Founded in 2003, the Company is headquartered in Edinburgh (UK) with offices in Denver (USA), Yokohama (Japan) and Shenzhen (China) supporting direct sales in Europe, Americas, Japan, China, and Australia, and channel sales in the rest of the world. DEM Solutions also works with a network of industry-expert engineering service partners worldwide supporting customers in deployment of EDEM simulation technology to address engineering challenges involving bulk particles.

Skinkers

Series A in 2007
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).

StrategyEye

Series A in 2007
StrategyEye has developed a B2B intelligence monitoring and editorial curation platform, enabling integration of proprietary content with relevant global news and blog sources in a highly structured manner – we index all content against taxonomy of Companies, Categories and Trigger Events (eg 'New Contract Win') tailored to each client. StrategyEye delivers two solutions using this hosted platform: - CONTENT MARKETING We enable brands to become publishers by helping them discover live breaking stories and then create and distribute their own compelling proprietary via web sites, social channels and via our newsletter builder. Our tools help clients promote thought leadership across multiple channels to support SEO and drive new customer leads. - CONTENT MONETIZATION We help any publisher or event organizer launch new, premium B2B intelligence products and generate incremental digital revenue through subscriptions or online advertising. We provide an end to end service including full editorial workflow, highly structured taxonomies and full output templates. Clients range from Haymarket, IPC, TimeWarner through to Progressive Media, Press Association and Clarion. We also deliver our own-label intelligence products which leveraging our in-house writers to deliver critical strategic intelligence on the Digital Media and Cleantech industries and are sold into 1,000+ executives and advisors globally on a subscription basis.

Mind Candy

Series A in 2006
Moshi provides a sleep and mindfulness app for kids featuring melodic stories created to help kids drift off to sleep quickly, calming guided meditation sessions with a playful Moshi twist, created to help kids relax and learn the basics of mindfulness, and a collection of completely original instrumentals, specifically composed to soothe and relax.

Skinkers

Seed Round in 2006
Skinkers is the UK based software developer that provides communication management software to help organisations overcome the current limitations of existing digital channels. We tick all the boxes! [Microsoft](http://www.crunchbase.com/organization/microsoft) and Skinkers signed a technology for equity deal in 2006, a first for Microsoft in Europe. Skinkers owns the intellectual property rights for the peer-to-peer technology developed by Microsoft Research. Microsoft has a minority equity stake in Skinkers. Skinkers and Microsoft won the UK Partnering for Innovation Award [this year](http://www.livestation.com/news/25-skinkers_and_microsoft_win_partnering_for_innovation_award). Livestation was released for beta testing in July to moderate [reviews](http://www.techcrunch.com/2007/07/06/first-look-at-livestation-not-much-to-report) and is expected to be released to the general public in the fall. While it is often compared to [Joost](http://www.crunchbase.com/organization/joost), Livestation is different in that it streams live video, as opposed to offering video On-Demand. Livestation official channels include Al Jazeera, BBC World News, Bloomberg Television, EuroNews (English, French, Italian and now Spanish), France 24, i>Tele, Russia Today and BBC World Service. A feature allowing viewers to add their own channels has just been launched and has over 400 channels already. To watch Livestation, users must download a free video player, which is available for beta [testing](http://www.livestation.com/user/signup). With added [funding](http://www.techcrunch.com/2007/10/29/skinkers-raises-16-million-series-b/), Skinkers is looking to compete in an increasingly [cluttered](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/) P2P IPTV space with competitors like [Zattoo](http://www.crunchbase.com/organization/Zattoo), [Babelgum](http://www.crunchbase.com/organization/babelgum), [Next.TV](http://www.techcrunch.com/2007/09/05/more-competition-for-iptv-hp-launching-nexttv/), as well as a number of Chinese based companies ([Sopcast](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPLive](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/), [PPMate](http://www.techcrunch.com/2007/07/13/live-p2p-television-streaming-now/)).

Haemostatix

Venture Round in 2005
Based at BioCity, Nottingham, UK, Haemostatix Ltd was co-founded in 2003 by Sarah Middleton and Professor Alison Goodall as a spin-out from the University of Leicester. The Company was established to commercialise a new technology platform based upon a specific peptide sequence that binds to fibrinogen – a protein essential to the formation of clots. The peptide is coupled to different forms of solid support or soluble carriers to create both topical and systemic haemostats. This new technology platform is the basis of a pipeline of first-in-class products to treat various forms of bleeding in surgery, trauma and in leukaemic patients.

Aspex Semiconductor

Series B in 2004
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Xention

Venture Round in 2003
Xention Limited, a biopharmaceutical company, specializes in the discovery and development of ion channel-modulating drugs. It offers drugs for the treatment of atrial fibrillation, overactive bladder, pain, and autoimmune diseases. Xention Limited was formerly known as Xention Discovery Ltd. and later changed its name to Xention Limited in October 2006. The company was founded in 2002 and is based in Cambridge, the United Kingdom.

Touch Clarity

Seed Round in 2000
Touch Clarity is a content targeting software company that improves customer acquisition and revenue for large consumer websites. Touch Clarity builds profile data on website visitors and use that data to target content and increase revenue and profit measurably. The profile building is automatic, continuous and performed in real time so that as events and behaviour change the systems quickly learns and adapts the served propositions accordingly.

LinkGuard

Venture Round in 2000
LinkGuard's current and future technology solutions focus on the detection, reporting, repair, bypass and prevention of broken links on the Internet.

Aspex Semiconductor

Series A in 2000
Aspex Semiconductor is a fabless semiconductor company that develops, manufactures, and distributes system-on-chip high-definition video compression and transcoding solutions for consumer electronic applications. It is specialized in the development of software programmable media processors and offers HD video transcoding chips. Aspex Semiconductor’s products are used in intelligent home gateways, PVR functionalities, Blu-ray or HD DVD recorders, networked digital televisions, television pause buttons, PCs and laptops, HD webcams, external adapters, and wireless HDMI applications. The company serves professional imaging and wireless infrastructure markets, including broadcast and digital cinema, medical imaging, machine vision, printing and document processing, and video compression markets. Aspex Semiconductor is based in Bradford, Somerset and, it sells its products through distributors in North America and the United Kingdom.

Event Zero

Series A in 2000
Event Zero is an independent software vendor with a focus on software products which bring insight and intelligence to the operation of IT services. Specializing in products for Microsoft Lync unified communications and green IT.

Nomad Payments

Private Equity Round in 2000
Nomad Payments is a leading provider of prepaid and debit card processing and licensed software.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.